Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Future Wearable Health Technology Co., Ltd., established on 2007-11-01, Business scope includes general business items:soft,Hardware Technology Development,Technical Services,technology transfer;Embedded software development and technical services;property lease;Domestic Trade;Operating import and export business;Exhibition planning,Cultural Event Planning(above according to the law,Administrative regulations,Decisions of the State Council and other regulations that require approval,Can only operate after obtaining relevant approval documents according to law);Cosmetics Wholesale;Cosmetics Retail;Rubber Products Sales;Household Goods Sales;leather goods manufacturing;furniture manufacturing;Household Goods Manufacturing;furniture sales;Leather Goods Sales;Manufacture of Home Textiles;textile manufacturing;needle textile sales;feather(velvet)And product manufacturing.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:smart wearable device,massage equipment,Massage equipment consumables,beauty appliances,Research and development of medical devices and related components,design,Production,Sales;Research and development of new materials,design,Production,Sales;Film and television program production Film and broadcast television program distribution,other telecommunications services

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Simpson Performance Products designs and manufactures racing safety equipment for the motorsports industry. The company offers head and neck restraints, helmets, racing suits, custom racing suits, twisted stitch off road seats, gloves, shoes, drag parachutes, child safety seats, headwear, logo apparel, apparel and bags, and underwear and accessories. It also offers team gear, including apparel, aprons, gear bags, gloves, shoes, custom embroidery products, and custom sublimated products. The company offers its products for various sports, such as circle track, dirt track, drag, karting, off road, motorcycle, and road racing sports. It sells its products through its retail stores and online. Simpson Performance Products was founded in 1959 and is headquartered in New Braunfels, Texas.

Schering AG was a research-centered German multinational pharmaceutical company headquartered in Wedding, Berlin, which operated as an independent company from 1851 to 2006. In 2006 it was bought by Bayer AG and merged to form the Bayer subsidiary Bayer Schering Pharma AG, which was renamed Bayer HealthCare Pharmaceuticals in 2011. Schering was listed on the Frankfurt Stock Exchange and had 26,000 employees as of 2004.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Zhejiang Cancer Hospital is a Chinese private company located in Hangzhou. The firm operates as an cancer hospital.

Tachi-S Co., Ltd. engages in the manufacture and sale of car seats and car seat components to automotive manufacturers. It supplies car seat systems for sports cars, sedans, mini vans, compact vehicles, sports utility vehicles, and trucks. The company was founded on April 7, 1954 and is headquartered in Tokyo, Japan.

INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION provides practical help for improving the technology of an industrial field.

ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation (R) technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS (R) line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology.

At Kura Oncology, They are committed to realizing the promise of precision medicines for cancer. The genomics revolution is transforming how they treat cancer. They now understand that how a patient responds to treatment depends in part on the genetic makeup of the cancer and, importantly, we have the knowledge and tools to create targeted treatments and companion diagnostics to identify those patients most likely to benefit. This new era offers the potential for innovative treatments that are safer and more effective for patients with particular cancers. They are leveraging our insights into cancer genetics as well as our core strength of translating novel science into life-saving medicines to advance a pipeline of precision medicines. Their development programs target cancers with high unmet need, including lung, colorectal, thyroid and pancreatic cancers as well as blood cancers such as lymphoma and leukemias.

Keystone Retaining Wall Systems, Inc., part of THE QUIKRETE Cos. LLC, is a company headquartered in the United States that manufactures concrete retaining wall systems.\nThe company says this about itself: The first segmental retaining wall company in the United States, Keystone Retaining Wall Systems® provides the preferred product solutions for the residential, commercial, institutional, retail and government markets. Keystone Retaining Wall Systems develops, markets and licenses concrete hardscape products to manufacturers across the globe. Keystone is a division of The QUIKRETE® Companies, which manufactures and distributes products from more than 200 facilities in the U.S., Canada, Puerto Rico and South America. Keystone Retaining Wall Systems is committed to helping engineers, architects, specifiers, contractors and homeowners bring projects to life.

Piramal Enterprises Ltd. engages in the business of pharmaceuticals and provision of financial services. It operates through the following segments: Pharmaceuticals Manufacturing and Services, Financial Services, and Healthcare Insights and Analytics. The Pharmaceuticals Manufacturing and Services segment operates through the following divisions: Pharma Solutions, Critical Care, Consumer Products Services and Imaging. The Financial Services segment offers a complete suite of financial products to meet the diverse needs of its customers. The Healthcare Insights and Analytics segment provides indispensable insights to life sciences companies as well as healthcare providers and payers through a variety of high value-added data and analytics, research reports, and knowledge-based services. The company was founded on April 26, 1947 and is headquartered in Mumbai, India.

Rinat, which means "happiness" in Hebrew, was formed in 2001 when Genentech, a leader in the development of therapeutic antibodies, narrowed its focus and spun out its key neuroscience assets under a broad license to Rinat. Genentech invested significant R&D resources in support of these assets over 15 years, and Rinat is now building on them as the pioneer in developing and commercializing antibody drugs for the treatment of diseases and disorders of the nervous system.

diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2) a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque rupture and thrombosis, not stenosis, that cause the majority of cardiovascular events. The PLAC Test is the only blood test cleared by the FDA as an aid in assessing risk for coronary heart disease, and ischemic stroke associated with atherosclerosis.

Signal Pharmaceuticals is a biopharmaceutical company that was founded by David Anderson (Senior VP & Head of Research), Alan Lewis (CEO), Mark Carmen, and Jackie Johnson and is based in California. It was acquired by Celgene in 2009

Tactile Systems Technology, Inc. is a medical technology company. It develops and provides innovative medical devices for the treatment of chronic diseases at home. The firm focus on advancing the standard of care in treating chronic diseases in the home setting to improve patient outcomes and quality of life and help control rising healthcare expenditures. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.